Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palliation of dyspnea with morphine in patients with interstitial lung disease
2015-002533-22Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of morphine in interstitial lung disease (ILD), sponsored by Aarhus University Hospital. Primary endpoint: Change in VAS dyspnea score after 7 days. Started Jun 2015; status: completed.
02
Drugs
morphine
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on 2015-002533-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002533-22.